About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COVID-19 Clinical Trials in Houston | 163 Studies

Clinical Trials COVID-19Houston

COVID-19 Clinical Trials in Houston

Find 163 clinical trials for covid-19 near Houston, Texas. Connect with research centers in your area.

All COVID-19 trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 163 trials

CompletedACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine)The purpose of this study is to evaluate the effectiveness of repurposed medications (study drug(s) in reducing symptoms of non-hospitalized participants with mild to moderate…NCT05890586·Gilbert, Arizona and 90 others

COVID-19 Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Approved for marketingExpanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19)The primary objective of this study is to provide expanded access of remdesivir (RDV) for the treatment of severe acute respiratory syndrome coronavirus (SARS-CoV2) infection.NCT04323761·Birmingham, Alabama and 271 others

CompletedBRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)This study looks at the safety and effectiveness of BRII-196/BRII-198 in treating COVID-19 in people who have been hospitalized with the infection.NCT05780424·Tucson, Arizona and 106 others

Active not recruitingStudy of VYD2311 for the Prevention of COVID-19The main purpose of this study is to test an investigational drug known as VYD2311, which is being developed to lower the risk of getting COVID-19.NCT07298434·Long Beach, California and 19 others

CompletedA Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/RitonavirThe purpose of this study is to learn about the safety and effects of nirmatrelvir/ritonavir for the potential treatment of COVID-19 rebound.NCT05567952·Mesa, Arizona and 83 others

CompletedClinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive SubjectsThis is a first in human clinical study to evaluate the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of RQ-01.NCT06063330·Los Angeles, California and 5 others

CompletedRECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID SymptomsThis study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within health care systems and in community settings where it can be…NCT05595369·Birmingham, Alabama and 68 others

CompletedACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19This study looks at the safety and effectiveness of different drugs in treating COVID-19 in people who have been hospitalized with the infection and who have acute respiratory…NCT04843761·Tucson, Arizona and 39 others

CompletedA Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy AdultsThe study is divided into 2 parts: Part 1 and Part 2.NCT05827926·Chandler, Arizona and 68 others

CompletedACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)The purpose of this study is to evaluate the effectiveness of repurposed medications (study drug(s) in reducing symptoms of non-hospitalized participants with mild to moderate…NCT05894577·Chandler, Arizona and 108 others

CompletedA Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 InfectionThe purpose of this clinical trial is to learn whether the study medicine prevent symptoms of COVID-19 in adults who have been exposed to household member(s) with a confirmed…NCT05047601·Pelham, Alabama and 169 others

TerminatedEfficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19Hope Biosciences is conducting a research study of an investigational product called allogeneic adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as treatment for…NCT04362189·Houston, Texas and 1 other

TerminatedEvaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).The primary hypothesis to be tested is whether or not there is a difference in time to sustained alleviation of all targeted COVID-19 signs and symptoms through Day 28 between…NCT05011513·Pelham, Alabama and 224 others

CompletedStudy of Sargramostim in Patients With COVID-19The purpose of this research is to find out if a drug (sargramostim) also known as Leukine® could help patient recover faster from COVID-19.NCT04411680·Fullerton, California and 10 others

CompletedACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600)The purpose of this study is to evaluate the effectiveness of repurposed medications (study drug(s) in reducing symptoms of non-hospitalized participants with mild to moderate…NCT05894538·Gilbert, Arizona and 92 others

TerminatedCOVID-19 Booster Vaccine in Autoimmune Disease Non-RespondersThis is a randomized, multi-site, adaptive, open-label clinical trial comparing the immune response to different additional doses of COVID-19 vaccine in participants with…NCT05000216·Los Angeles, California and 28 others

UnknownCardiovascular Manifestations of COVID-19Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen responsible for the novel coronavirus disease 2019 (COVID-19).NCT04335630·Houston, Texas

CompletedACTIV-2: A Study for Outpatients With COVID-19Drug studies often look at the effect one or two drugs have on a medical condition, and involve one company.NCT04518410·Anniston, Alabama and 251 others

CompletedAdaptive COVID-19 Treatment Trial 3 (ACTT-3)ACTT-3 will evaluate the combination of interferon beta-1a and remdesivir compared to remdesivir alone. Subjects will be assessed daily while hospitalized.NCT04492475·Birmingham, Alabama and 63 others

TerminatedStudy of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19The purpose of this study is to assess the safety and efficacy of merimepodib (MMPD) oral solution when administered in combination with remdesivir in adult patients with advanced…NCT04410354·Phoenix, Arizona and 9 others

Page 1 of 9Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia